微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 43.54% | 5.37% | 10.94% | 17/52 | 36.42% | 诺泰生物 | 69.32% | 行业排名> |
| 2024-06-30 | 39.25% | 2.02% | -3.8% | 28/52 | 36.51% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 40.8% | 11.9% | -4.86% | 19/52 | 36.38% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.89% | -10.67% | 3.78% | 18/52 | 38.59% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 41.33% | -18.41% | 7.42% | 26/52 | 40.29% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 38.47% | -24.34% | 5.51% | 32/52 | 40.13% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 36.46% | -29.34% | -24.05% | 32/52 | 39.27% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 48.01% | -3.93% | -5.22% | 13/52 | 40.44% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 50.65% | 4.96% | -0.39% | 10/52 | 41.37% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 50.85% | 3.74% | -1.46% | 9/52 | 40.21% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 51.6% | 2% | 3.27% | 8/52 | 38.93% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 49.97% | -0.3% | 3.56% | 13/52 | 42.21% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 48.26% | 2% | -1.55% | 15/52 | 43.4% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 49.01% | -6.5% | -2.21% | 16/52 | 42.88% | 南华生物 | 83.19% | 行业排名> |
| 2020-12-31 | 50.12% | 11.26% | -4.39% | 17/52 | 38.9% | 南华生物 | 83.9% | 行业排名> |
| 2020-06-30 | 52.42% | 2% | 16.37% | 11/52 | 39.73% | 成都先导 | 79.36% | 行业排名> |
| 2019-12-31 | 45.05% | 29.99% | 29.99% | 21/52 | 43.15% | 成都先导 | 75.92% | 行业排名> |
| 2018-12-31 | 34.66% | 4.9% | 4.9% | 36/52 | 42.47% | 南华生物 | 78.74% | 行业排名> |
| 2017-12-31 | 33.04% | 3.93% | 3.93% | 33/52 | 41.42% | 成都先导 | 80.82% | 行业排名> |